ubiquitinproteasom
system
known
util
coxsackieviru
facilit
propag
within
host
cell
present
studi
explor
role
tripeptidyl
peptidas
ii
tppii
serin
peptidas
contribut
protein
turnov
act
downstream
proteasom
regul
coxsackieviru
infect
inhibit
tppii
affect
viru
replic
cell
function
proteasom
howev
proteasom
impair
tppii
appear
serv
altern
maintain
low
level
viru
infect
result
suggest
import
function
tppii
mainten
viral
growth
may
implic
antivir
therapi
coxsackieviru
type
widespread
common
etiolog
agent
caus
myocard
pancreat
previous
demonstr
critic
role
ubiquitinproteasom
system
up
control
replic
within
host
cell
up
major
intracellular
protein
degrad
pathway
contribut
significantli
regul
mani
essenti
cellular
function
remov
misfold
damag
protein
well
recycl
shortliv
regulatori
protein
provid
evid
util
function
host
up
enhanc
effici
replic
host
cell
show
inhibit
proteasom
function
chemic
inhibitor
significantli
reduc
infect
vitro
result
attenu
myocardi
damag
vivo
proteasomeindepend
proteolysi
emerg
altern
pathway
proteasomemedi
protein
turnov
tripeptidyl
peptidas
ii
tppii
giant
intracellular
serin
peptidas
exhibit
exoand
endoproteolyt
activ
believ
tppii
act
downstream
proteasom
cleav
proteasomegener
peptid
tripeptid
degrad
free
amino
acid
aminopeptidas
addit
role
relat
gener
protein
turnov
respons
mainten
numer
fundament
cellular
function
tppii
play
essenti
role
mhc
class
antigen
process
via
digest
proteasom
product
smaller
peptid
suitabl
antigen
present
adapt
proteolyt
respons
impair
proteasom
function
report
play
compensatori
role
regul
protein
degrad
tppii
appear
make
essenti
contribut
proteolyt
activ
substitut
proteasom
proteasomeinhibit
cell
cell
loss
proteasom
function
tppii
shown
exhibit
enhanc
activ
complement
proteasom
activ
object
studi
explor
role
tppii
control
infect
presenc
absenc
proteasom
inhibit
demonstr
inhibit
tppii
affect
replic
cell
normal
function
proteasom
howev
loss
proteasom
activ
tppii
activ
appear
serv
altern
proteolyt
pathway
maintain
minimum
infect
inhibit
tppii
reduc
replic
synergist
fashion
combin
proteasom
inhibitor
result
suggest
import
function
tppii
regul
viru
infect
hela
cell
purchas
american
type
cultur
collect
rockvil
md
grown
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
lgml
penicillinstreptomycin
invitrogen
life
technolog
co
humidifi
incub
mous
monoclon
antibodi
obtain
dakocytom
monoclon
antibactin
antibodi
sigma
horseradish
peroxidaseconjug
secondari
antibodi
purchas
santa
cruz
biotechnolog
proteasom
inhibitor
lactacystin
tppii
inhibitor
halaalaphechloromethylketon
haafcmk
obtain
calbiochem
hela
cell
preincub
increas
concentr
variou
inhibitor
specifi
figur
legend
min
cell
infect
kandolf
strain
dr
reinhard
kandolf
univers
tubingen
germani
multipl
infect
mock
infect
phosphat
buffer
salin
pb
h
infect
cell
wash
pb
replac
new
dmem
contain
fresh
inhibitor
equal
amount
protein
subject
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
transfer
nitrocellulos
membran
previous
describ
membran
block
nonfat
dri
milk
solut
contain
tween
h
blot
probe
h
primari
antibodi
follow
incub
h
secondari
antibodi
conjug
horseradish
peroxidaseconjug
secondari
antibodi
immunoreact
protein
band
visual
enhanc
chemiluminesc
ge
healthcar
viral
titer
supernat
evalu
agar
overlay
plaqu
assay
previous
describ
brief
supernat
serial
dilut
overlaid
monolay
hela
cell
h
incub
medium
remov
complet
dmem
contain
agar
ad
three
day
later
cell
fix
carnoy
fix
acet
acid
ethanol
stain
crystal
violet
plaqu
count
viral
titer
calcul
plaqu
form
unit
per
millilit
cell
lysat
prepar
collect
lysi
buffer
mm
pyrophosph
mm
naf
mm
nacl
mm
edta
mm
egta
lm
na
vo
mm
hepe
ph
triton
contain
proteas
inhibitor
previous
describ
chymotrypsinlik
activ
proteasom
tppii
activ
determin
use
synthet
fluorogen
substrat
calbiochem
determin
role
tppii
regul
infect
first
examin
effect
tppii
inhibit
protein
express
progeni
viru
titer
hela
cell
preincub
increas
concentr
tppii
inhibitor
haafcmk
min
follow
infect
h
proteasom
inhibitor
lactacystin
use
show
effect
proteasom
inhibit
replic
western
blot
result
fig
plaqu
assay
data
fig
show
treatment
tppii
inhibitor
result
chang
viral
protein
express
viru
titer
respect
howev
proteasom
inhibitor
lactacystin
dramat
reduc
viral
protein
express
viral
growth
rate
consist
previous
report
result
suggest
activ
tppii
requir
mainten
viral
growth
host
cell
possess
normal
proteasom
function
report
tppii
complement
proteasom
activ
proteasom
function
damag
next
determin
role
tppii
regul
viral
infect
cell
impair
proteasom
function
specif
examin
whether
tppii
inhibit
reduc
proteasom
inhibitionmedi
suppress
replic
hela
cell
incub
increas
dose
tppii
inhibitor
presenc
lm
shown
fig
treatment
led
decreas
viral
protein
express
viru
titer
addit
tppii
inhibitor
synerg
reduc
viral
infect
dosedepend
manner
suggest
tppii
activ
may
compens
loss
proteasom
function
maintain
low
level
propag
cell
examin
tppii
activ
cours
viral
infect
fig
show
tppii
activ
chang
h
postinfect
either
presenc
absenc
proteasom
inhibitor
lm
previous
demonstr
proteasom
activ
also
unalt
throughout
time
cours
infect
togeth
result
suggest
infect
appear
affect
activ
proteasom
downstream
executor
tppii
valid
impact
proteasom
inhibitor
tppii
inhibitor
chymotrypsinlik
activ
proteasom
tppii
activ
perform
proteolyt
assay
use
two
differ
synthet
fluorogen
peptid
substrat
found
differ
dose
use
studi
ie
lm
dramat
decreas
chymotrypsinlik
activ
concentrationdepend
manner
anticip
fig
howev
treatment
differ
concentr
tppii
inhibitor
appear
inhibitori
effect
proteasom
activ
fig
led
dosedepend
decreas
tppii
activ
fig
interestingli
found
higher
dose
ie
lm
also
inhibit
tppii
activ
suggest
inhibitori
effect
viral
replic
dose
consequ
inhibit
proteasom
tppii
activ
final
demonstr
combin
lm
dose
signific
inhibit
tppii
activ
fig
increas
concentr
tppii
inhibitor
significantli
decreas
tppii
activ
fig
influenc
chymotrypsinlik
activ
fig
collect
result
suggest
function
tppii
play
compensatori
role
regul
infect
proteasom
function
lost
target
proteasom
suggest
promis
therapeut
option
infect
mani
virus
includ
coxsackievirus
coronavirus
retrovirus
cytomegalovirus
influenza
virus
demonstr
gener
inhibit
proteolyt
activ
proteasom
result
dramat
reduct
coxsackievir
replic
virusinduc
pathogenesi
howev
function
proteasom
degre
redund
treatment
proteasom
inhibitor
shown
abl
induc
develop
adapt
confer
cell
resist
proteasom
inhibit
altern
proteas
impair
proteasom
identifi
tppii
larg
serin
peptidas
contribut
protein
turnov
antigen
present
degrad
proteasomegener
peptid
increas
evid
suggest
tppii
stress
condit
may
compens
substitut
function
proteasom
present
studi
explor
potenti
role
tppii
regul
replic
presenc
absenc
proteasom
inhibitor
demonstr
essenti
function
tppii
mainten
viral
latenc
loss
proteasom
activ
potenti
mechan
tppii
pathway
assist
replic
absenc
function
proteasom
like
relat
role
maintain
gener
protein
turnov
mani
host
intracellular
protein
function
barrier
viral
replic
exampl
recent
demonstr
tumor
suppressor
protein
host
protein
increas
proteolysi
protein
benefici
replic
thu
postul
tppii
function
maintain
replic
facilit
degrad
antivir
host
protein
cell
lysat
harvest
subject
tppii
activ
assay
fluorogen
peptid
substrat
haafamc
describ
section
result
display
mean
standard
deviat
sd
n
statist
signific
determin
use
unpair
student
ttest
statist
differ
two
group
three
time
cours
observ
peptid
aldehyd
inhibit
function
proteasom
act
proteasom
substrat
analog
addit
proteasom
inhibit
inhibit
lysosom
calpain
proteas
activ
studi
also
demonstr
nonspecif
effect
inhibit
tppii
activ
thu
strike
inhibit
effect
higher
dose
replic
shown
previou
studi
current
studi
appear
due
blockag
proteasom
tppii
activ
conclus
data
provid
first
evid
tppii
partial
substitut
compromis
proteasom
function
serv
altern
pathway
favor
viral
growth
within
host
cell
find
provid
potenti
use
inform
novel
antivir
drug
design
result
express
amount
amc
form
enzymat
cleavag
substrat
mean
sd
n
p
p
dmso
treat
control
group
